Pharmacological profile of YM348, a novel, potent and orally active 5-HT 2C receptor agonist

By Kimura Y.   Hatanaka K.-i.   Naitou Y.   Maeno K.   Shimada I.   Koakutsu A.   Wanibuchi F.   Yamaguchi T.  

European Journal of Pharmacology, Vol. 483, Iss. 1, 2004-01 ,pp. : 37-43

Elsevier

Access to resources Recommend Favorite

Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT 1A receptors

By Tordera R.M.   Monge A.   Del Ro J.   Lasheras B.  

European Journal of Pharmacology, Vol. 442, Iss. 1, 2002-05 ,pp. : 63-71

Elsevier

Access to resources Recommend Favorite

Antidepressant-like effects of the novel, selective, 5-HT_2C receptor agonist WAY-163909 in rodents

By Rosenzweig-Lipson Sharon   Sabb Annmarie   Stack Gary   Mitchell Paul   Lucki Irwin   Malberg Jessica   Grauer Steve   Brennan Julie   Cryan John   Sukoff Rizzo Stacey   Dunlop John   Barrett James   Marquis Karen  

Psychopharmacology, Vol. 192, Iss. 2, 2007-06 ,pp. : 159-170

Springer Publishing Company

Access to resources Recommend Favorite

EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT 1A receptor agonistic properties

By Bartoszyk G.D.   Hegenbart R.   Ziegler H.  

European Journal of Pharmacology, Vol. 322, Iss. 2, 1997-03 ,pp. : 147-153

Elsevier

Access to resources Recommend Favorite

Catalepsy induced by the 5-HT 1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram

By Eltayb A.   Svensson T.H.   Ahlenius S.  

European Journal of Pharmacology, Vol. 411, Iss. 3, 2001-01 ,pp. : 275-277

Elsevier

Access to resources Recommend Favorite